HPK1-IN-27
HPK1-IN-27 is a potent inhibitor of HPK1. MAP4K1 is also known as hematopoietic progenitor kinase 1 (HPK1) . MAP4K1 is a serine/threonine kinase and member of the germinal center kinase family. HPK1-IN-27 has the potential for the research of cancer diseases (extracted from patent WO2019016071A1, compound 38) [1].
Product Specifications
CAS Number
2268794-52-9
UNSPSC
12352005
Target
MAP4K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hpk1-in-27.html
Solubility
10 mM in DMSO
Smiles
OCC1(C)CN=C(NC2=CC(F)=C(OC3=C4C(NC=C4C5=CC=C(OC)C=C5F)=NC=C3)C(F)=C2)OC1
Molecular Formula
C26H23F3N4O4
Molecular Weight
512.48
References & Citations
[1]Jeffrey Stuart MOWAT, et al. Substituted pyrrolopyridine-derivatives. Patent WO2019016071A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL700404V 500 µL Each
Olr1743 Rat shRNA Lentiviral Particle (Locus ID 294197)
Sign In for Pricing
View Details 
MBS6300864-01 0.2 mL
GABRB2, CT (GABRB2, Gamma-aminobutyric acid receptor subunit beta-2, GABA(A) receptor subunit beta-2) (Biotin)
Sign In for Pricing
View Details MBS6300864-02 5x 0.2 mL
GABRB2, CT (GABRB2, Gamma-aminobutyric acid receptor subunit beta-2, GABA(A) receptor subunit beta-2) (Biotin)
Sign In for Pricing
View Details